Objective: The clinical manifestation of amyotrophic lateral sclerosis (ALS) is characterized by motor neuron degeneration, whereas frontotemporal dementia (FTD) patients show alterations of behavior and cognition. Both share repeat expansions in C9orf72 as the most prevalent genetic cause. Before disease-defining symptoms onset, structural and functional changes at cortical level may emerge in C9orf72 carriers. Here, we characterized oculomotor parameters and their association to neuropsychological domains in apparently asymptomatic individuals with mutations in ALS/FTD genes.

Patients And Methods: Forty-eight carriers of ALS genes, without any clinical symptoms underwent video-oculographic examination, including 22 subjects with C9orf72 mutation, 17 with SOD1, and 9 with other ALS associated gene mutations (n = 3 KIF5A; n = 3 FUS/FUS + TBK1; n = 1 NEK1; n = 1 SETX; n = 1 TDP43). A total of 17 subjects underwent a follow-up measurement. Data were compared to 54 age- and gender-matched healthy controls. Additionally, mutation carriers performed a neuropsychological assessment.

Results: In comparison to controls, the presymptomatic subjects performed significantly worse in executive oculomotor tasks such as the ability to perform correct anti-saccades. A gene mutation subgroup analysis showed that dysfunctions in C9orf72 carriers were much more pronounced than in SOD1 carriers. The anti-saccade error rate of ALS mutation carriers was associated with cognitive deficits: this correlation was increased in subjects with C9orf72 mutation, whereas SOD1 carriers showed no associations.

Conclusion: In C9orf72 carriers, executive eye movement dysfunctions, especially the increased anti-saccade error rate, were associated with cognitive impairment and unrelated to time. These oculomotor impairments are in support of developmental deficits in these mutations, especially in prefrontal areas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357645PMC
http://dx.doi.org/10.1007/s00415-021-10510-zDOI Listing

Publication Analysis

Top Keywords

c9orf72 carriers
12
carriers
9
eye movement
8
subjects c9orf72
8
c9orf72 mutation
8
mutation sod1
8
mutation carriers
8
sod1 carriers
8
anti-saccade error
8
error rate
8

Similar Publications

The largest risk factor for dementia is age. Heterochronic blood exchange studies have uncovered age-related blood factors that demonstrate 'pro-aging' or 'pro-youthful' effects on the mouse brain. The clinical relevance and combined effects of these factors for humans is unclear.

View Article and Find Full Text PDF

Semantic behavioral variant frontotemporal dementia and semantic dementia associated with mutations.

Amyotroph Lateral Scler Frontotemporal Degener

December 2024

Institute of Neurology, Azienda Ospedaliero Universitaria di Cagliari, University of Cagliari, Cagliari, Italy.

Frontotemporal dementia (FTD) is a highly heritable group of neurodegenerative disorders, characterized by varying clinical and pathological features. gene has been described worldwide within the FTD/ALS spectrum but its association with right and left temporal variant of FTD (tvFTD) is still unclear. This study aimed to reclassify a Sardinian FTD cohort according to proposed criteria for the semantic behavioral variant FTD (sbvFTD), explore mutations' association with tvFTD, and review related literature.

View Article and Find Full Text PDF

RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD.

Life Sci Alliance

February 2025

Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield, UK

A G4C2 hexanucleotide repeat expansion in is the most common cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Bidirectional transcription and subsequent repeat-associated non-AUG (RAN) translation of sense and antisense transcripts leads to the formation of five dipeptide repeat (DPR) proteins. These DPRs are toxic in a wide range of cell and animal models.

View Article and Find Full Text PDF

Frontotemporal Dementia.

Continuum (Minneap Minn)

December 2024

Article Synopsis
  • - The article outlines frontotemporal dementia (FTD) by focusing on three core syndromes: behavioral variant FTD and two types of progressive aphasia (nonfluent and semantic variants), which are linked to specific protein abnormalities in the brain.
  • - It highlights that FTD is more heritable than Alzheimer's and indicates genetic variations, such as in C9orf72 and MAPT, are found in over 10% of cases, which help understand its pathology through clinical presentations and imaging.
  • - Although there are no FDA-approved treatments for FTD yet, ongoing clinical trials aim to find disease-modifying therapies, while current management strategies address behavioral and language issues through non-drug methods or off-label medication use. *
View Article and Find Full Text PDF

Reward processing deficits arise early in familial frontotemporal dementia.

Front Neurosci

November 2024

Department of Neurology, Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, United States.

Reward processing involves evaluation of stimuli to inform what an individual works to pursue or avoid. Patients with behavioral variant frontotemporal dementia (bvFTD) often display reward processing changes, including insensitivity to aversive stimuli. It is unknown how early in the disease course reward changes are detectable.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!